Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 396 participants.

Also called NCT01891058

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 396 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01891058
Other papers using this trial's data
  • Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial Lancet (London, England), 2020-02-01 DOI, PubMed 32007169

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01891058. Randomized; single masking; primary purpose treatment. Start 2013-07-18 (actual); primary completion 2018-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED
Acronym
RAFF-2
Intervention (Device)
drug-shock vs shock only
Lead sponsor
Ottawa Hospital Research Institute (class: other)
Collaborator
The Ottawa Hospital (class: other)

Record details

Record id
cardio:ct-nct01891058
Content hash
4e7afd0bf13e543b31ac4385e8c878a7ca4bcf9d4d6c793ee33b303afb09d166